31st May, 2021 Morning Brief

Market will open on a flat note today in line with global cues. 

Asian shares edged higher on Monday, looking to extend their recent rally to a third week should U.S. jobs figures show the expected revival in hiring in May and keep the global recovery on track.

MSCI's broadest index of Asia-Pacific shares outside Japan was a fraction firmer, having rallied 2.2% last week. Japan's Nikkei was flat, while Australia rose 0.2% to a fresh all-time peak.

US stocks climbed on Friday as investors brushed off a stronger-than-expected inflation reading, as both the Dow and S&P 500 indexes clinched their first weekly gain in the past three weeks.

The Dow Jones Industrial Average rose 64.81 points, or 0.19%, to 34,529.45, the S&P 500 gained 3.23 points, or 0.08%, at 4,204.11 and the Nasdaq Composite added 12.46 points, or 0.09%, at 13,748.74.

Results Today : 

Aurobindo Pharma, Chemcon Speciality Chemicals

🎯 Bank of Baroda : 

The bank posted loss of Rs 1,046.5 crore in Q4FY21 against profit of Rs 506.59 crore in Q4FY20. Net interest income rose Rs 7,106.62 crore from Rs 6,798.18 crore YoY.

🎯 Divi's Laboratories : 

Consolidated profit increased to Rs 502.02 crore in Q4FY21, from Rs 388.23 crore in Q4FY20. Consolidated revenue jumped to Rs 1,788.19 crore, from Rs 1,389.71 crore YoY.

Positive. 

🎯 Affle (India): The company reported consolidated profit at Rs 58.6 crore in Q4FY21 against Rs 15.29 crore in Q4FY20, revenue jumped to Rs 141.57 crore from Rs 80 crore YoY.

Positive. 

🎯 Fortis Healthcare : The company reported consolidated profit at Rs 62.36 crore in Q4FY21 against loss of Rs 41.24 crore in Q4FY20, revenue rose to Rs 1,252.44 crore from Rs 1,112.92 crore YoY.

Positive. 

🎯 Himatsingka Seide : The company reported consolidated profit at Rs 37.57 crore in Q4FY21 against loss of Rs 68.84 crore in Q4FY20, revenue jumped to Rs 746.04 crore from Rs 434.6 crore YoY.

Positive. 

Kotak Mahindra Bank: The bank approved the proposal for issuance of unsecured, redeemable, non-convertible debentures/bonds/other debt securities, on private placement basis for an amount up to Rs 5,000 crore, in one or more tranches.

🎯 Cadila Healthcare : 

Zydus Cadila received final approval from USFDA for Fluphenazine hydrochloride tablets, which are used to treat symptoms of a certain type of mental/mood condition (schizophrenia).

🎯 Paisalo Digital : State Bank of India bought 4,37,498 equity shares in Paisalo Digital at Rs 570 per share on the NSE, the bulk deals data showed.

Punjab National Bank: The bank intends to divest its stake in Canara HSBC OBC Life Insurance, an associate company of the bank, at an appropriate time depending ,/on market conditions and available options.